News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,203 Results
Type
Article (41184)
Company Profile (306)
Press Release (675713)
Section
Business (210009)
Career Advice (2058)
Deals (36173)
Drug Delivery (101)
Drug Development (82077)
Employer Resources (174)
FDA (16558)
Job Trends (15294)
News (353543)
Policy (33220)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (6)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2683)
Accelerated approval (4)
Adcomms (20)
Allergies (81)
Alliances (51331)
ALS (84)
Alzheimer's disease (1388)
Antibody-drug conjugate (ADC) (118)
Approvals (16559)
Artificial intelligence (257)
Autoimmune disease (16)
Automation (14)
Bankruptcy (361)
Best Places to Work (12012)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (208)
Bladder cancer (59)
Brain cancer (26)
Breast cancer (260)
Cancer (2063)
Cardiovascular disease (165)
Career advice (1718)
Career pathing (30)
CAR-T (146)
Cell therapy (413)
Cervical cancer (19)
Clinical research (66570)
Collaboration (814)
Compensation (467)
Complete response letters (20)
COVID-19 (2615)
CRISPR (37)
C-suite (224)
Cystic fibrosis (98)
Data (2011)
Decentralized trials (2)
Denatured (26)
Depression (41)
Diabetes (252)
Diagnostics (6565)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (46)
Drug discovery (119)
Drug pricing (99)
Drug shortages (26)
Duchenne muscular dystrophy (86)
Earnings (87762)
Editorial (32)
Employer branding (21)
Employer resources (148)
Events (116242)
Executive appointments (680)
FDA (17715)
Featured Employer (55)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (729)
Gene editing (101)
Generative AI (22)
Gene therapy (290)
GLP-1 (700)
Government (4496)
Grass and pollen (4)
Guidances (49)
Healthcare (19536)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (27)
Infectious disease (2749)
Inflammatory bowel disease (135)
Inflation Reduction Act (9)
Influenza (48)
Intellectual property (89)
Interviews (322)
IPO (16809)
IRA (41)
Job creations (3726)
Job search strategy (1461)
Kidney cancer (9)
Labor market (34)
Layoffs (469)
Leadership (17)
Legal (8053)
Liver cancer (73)
Lung cancer (297)
Lymphoma (135)
Machine learning (4)
Management (58)
Manufacturing (278)
MASH (61)
Medical device (13942)
Medtech (13947)
Mergers & acquisitions (19855)
Metabolic disorders (640)
Multiple sclerosis (73)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (25)
Neuroscience (1883)
NextGen: Class of 2025 (6741)
Non-profit (4686)
Northern California (2483)
Now hiring (37)
Obesity (344)
Opinion (214)
Ovarian cancer (72)
Pain (79)
Pancreatic cancer (77)
Parkinson's disease (140)
Partnered (20)
Patents (210)
Patient recruitment (98)
Peanut (47)
People (59002)
Pharmaceutical (74)
Pharmacy benefit managers (18)
Phase I (20788)
Phase II (29320)
Phase III (21792)
Pipeline (1067)
Podcasts (56)
Policy (115)
Postmarket research (2578)
Preclinical (8780)
Press Release (70)
Prostate cancer (95)
Psychedelics (30)
Radiopharmaceuticals (260)
Rare diseases (366)
Real estate (6143)
Recruiting (65)
Regulatory (22651)
Reports (47)
Research institute (2439)
Resumes & cover letters (350)
Rett syndrome (4)
RNA editing (4)
RSV (39)
Schizophrenia (66)
Series A (126)
Series B (82)
Service/supplier (17)
Sickle cell disease (54)
Southern California (2155)
Special edition (15)
Spinal muscular atrophy (151)
Sponsored (29)
Startups (3730)
State (2)
Stomach cancer (13)
Supply chain (62)
Tariffs (11)
The Weekly (28)
United States (21948)
Vaccines (660)
Venture capitalists (37)
Webinars (13)
Weight loss (228)
Women's health (35)
Worklife (16)
Date
Today (121)
Last 7 days (704)
Last 30 days (2766)
Last 365 days (34548)
2025 (8542)
2024 (36343)
2023 (41218)
2022 (52323)
2021 (56914)
2020 (55417)
2019 (48340)
2018 (36461)
2017 (33228)
2016 (32773)
2015 (38911)
2014 (32426)
2013 (27382)
2012 (29566)
2011 (30219)
2010 (28152)
Location
Africa (753)
Alabama (50)
Alaska (7)
Arizona (231)
Arkansas (14)
Asia (39633)
Australia (6434)
California (5677)
Canada (1905)
China (492)
Colorado (256)
Connecticut (269)
Delaware (131)
Europe (86663)
Florida (836)
Georgia (206)
Idaho (59)
Illinois (529)
India (25)
Indiana (302)
Iowa (9)
Japan (144)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (61)
Maryland (848)
Massachusetts (4346)
Michigan (216)
Minnesota (385)
Mississippi (2)
Missouri (84)
Montana (30)
Nebraska (25)
Nevada (57)
New Hampshire (65)
New Jersey (1645)
New Mexico (30)
New York (1645)
North Carolina (993)
North Dakota (8)
Northern California (2483)
Ohio (193)
Oklahoma (15)
Oregon (34)
Pennsylvania (1279)
Puerto Rico (10)
Rhode Island (28)
South America (1135)
South Carolina (19)
South Dakota (1)
Southern California (2155)
Tennessee (97)
Texas (851)
Utah (172)
Virginia (137)
Washington D.C. (62)
Washington State (532)
West Virginia (3)
Wisconsin (57)
717,203 Results for "luna innovations inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Bio NC
Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
Asensus Surgical, Inc. announced a key development milestone for LUNA™, the Company’s second-generation surgical robotic system.
January 4, 2024
·
5 min read
Bio NC
Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System
Asensus Surgical, Inc. announced an agreement with diversified manufacturer Flex for design and advanced manufacturing services for Asensus’s previously-announced LUNA Surgical System, a next-generation surgical robot platform.
November 13, 2023
·
4 min read
Biotech Bay
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the company will present the 26-week landmark interim analysis from its ongoing LUNA Phase 2 study of ixoberogene soroparvovec (Ixo-vec) for the treatment of wet age-related macular degeneration (wet AMD) at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting being held in Stockholm, Sweden from July 17 - 20, 2024.
April 25, 2024
·
4 min read
Press Releases
Luna Diabetes Announces Start of Pivotal Study to Bring Automated Insulin Delivery to Insulin Pens
October 24, 2024
·
2 min read
Drug Development
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Positive results from the LUNA 3 phase 3 study demonstrated that rilzabrutinib 400 mg twice daily orally achieved the primary endpoint of durable platelet response in adult patients with persistent or chronic immune thrombocytopenia.
April 23, 2024
·
8 min read
Press Releases
Tioga Cardiovascular Announces First-in-Human Cases With Its Luna™ Transcatheter Mitral Valve Replacement (TMVR) System
October 24, 2024
·
2 min read
Press Releases
Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements
November 18, 2024
·
15 min read
Drug Development
Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024
Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that the company will host a webcast to review preliminary efficacy and safety data from its ongoing LUNA Phase 2 study of ixoberogene soroparvovec (Ixo-vec) for the treatment of wet age-related macular degeneration (wet AMD) on Thursday, February 8th, 2024 at 8:00am ET.
February 1, 2024
·
4 min read
Drug Development
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD
Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for highly prevalent ocular diseases, today announced preliminary safety and efficacy data from the ongoing LUNA Phase 2 trial in patients with wet age-related macular degeneration (AMD).
February 8, 2024
·
10 min read
Press Releases
Adverum Biotechnologies Announces Webcast to Report 52-Week LUNA Phase 2 Clinical Data and 4-Year OPTIC Clinical Data, and to Provide Key Pivotal Program Design Elements
November 18, 2024
·
3 min read
1 of 71,721
Next
